Webinar

2023 Leadership Insights Series

We’re committed to sharing valuable insights with hospital and health system leaders like you.

Making connections, spotting trends, advancing strategies

We heard that frequent, meaningful communication is important to you. That’s why we created this series. Through this channel, we’re focused on creating connections and facilitating discussions around industry trends, market dynamics, and our long-term organizational strategy. 

Lisa Scholz, VP of 340B Enterprise Strategy

340B Year-in-Review

Join Lisa Scholz, VP, 340B Enterprise Strategy at Cencora for a recap of all things 340B in 2023. Lisa will share about 340B policies and where they stand today as well as how  Accelerate Pharmacy Solutions' 340B team can partner with you. She will also talk about innovation in the 340B space and where she sees the landscape going in 2024. 

Beth McMahon, Senior VP, Emerging Therapies & Channel Strategy

Strategic Global Sourcing

During the session, Lauren and Beth discuss Cencora's approach to sourcing for various product categories such as cell and gene therapies, biosimilars, and limited distribution drugs (LDDs). Additionally, they will provide insights into contract renewals with our manufacturer partners.

Hilary Knepper, VP of Commercial Operations
Matt Sample, Senior VP of Manufacturer and Replenishment Operations

Secure Supply Chain and DSCSA

Joining Matt in this discussion is Hillary Knepper, a senior health systems leader and National Vice President of Customer Operation at Cencora. Together, they'll discuss the implications of the new regulations for hospitals and health systems, and what you need to know to stay compliant.

Want to hear more from Cencora leaders on industry hot topics? 

Dive into our additional Leadership Insights Series to gain valuable insights from health system leaders.

Related resources

White paper

Demystifying four common specialty distribution channel misconceptions

Article

AI-powered tools for pricing: Key takeaways from ISPOR Europe 2025

Article

Rethinking oncology launches: How the next generation of patients is reshaping strategies